Siemens Healthineers has completed the acquisition Corindus Vascular Robotics, effective 29 October 2019.
Bernd Montag, CEO of Siemens Healthineers, said: "With the completion of the acquisition, we are opening up a new field for our Advanced Therapies business, tapping into adjacent growth markets with great potential for the future. We are taking an important step forward in the upgrading phase of our 2025 strategy.”
Corindus is now part of the Advanced Therapies reporting segment. Headquartered in Waltham, Massachusetts, the company develops, produces and sells a robotic-assisted platform. It is currently an FDA cleared and CE marked robotic system for endo-vascular coronary and peripheral vascular interventions – helping physicians to control guide catheters, guide wires, balloon or stent implants via integrated imaging. The physician does not have to stand directly at the angiography table as is current practice but can control the procedure with a separate controlling module and is therefore exposed to less radiation.
Mark J Toland, former president and CEO of Corindus, who will continue to manage the business within Siemens Healthineers, said: “The combination of Siemens Healthineers’ strong medical technology portfolio with its digital platforms and solutions, together with Corindus’ precision robotics platform, has the potential to transform healthcare delivery so that, together, we can provide better care at lower cost.”
